MedX Health Corp Total Assets
MedX Health Corp total assets. Based on the latest financial reports, MedX Health Corp (MDX) holds total assets worth CA$1.26 Million CAD (≈ $908.08K USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see MedX Health Corp stock valuation for the company's overall valuation and market capitalisation.
Total Assets of MedX Health Corp (2013–2024)
Total assets of MedX Health Corp from 2013 to 2024. This chart illustrates how MedX Health Corp's total assets have evolved over time, based on quarterly financial data. See MedX Health Corp (MDX) share price today for real-time trading data and today's change.
MedX Health Corp - Asset Composition Analysis
MedX Health Corp Total Assets Breakdown (December 2024)
MedX Health Corp total assets breakdown as of December 2024. MedX Health Corp's total assets of CA$1.26 Million consist of 95.6% current assets and 4.5% non-current assets.
| Asset Category | Amount (CAD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CA$0.00 | 17.9% |
| Accounts Receivable | CA$29.54K | 3.3% |
| Inventory | CA$376.53K | 42.6% |
| Property, Plant & Equipment | CA$0.00 | 0.0% |
| Intangible Assets | CA$0.00 | 0.0% |
| Goodwill | CA$0.00 | 0.0% |
Asset Composition Trend (2013–2024)
This chart illustrates how MedX Health Corp's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore MDX current assets to equity ratio to assess how much short-term liquidity the company maintains relative to its equity base.
Key Asset Composition Facts
- Current vs. Non-Current Assets: MedX Health Corp's current assets represent 95.6% of total assets in 2024, an increase from 66.8% in 2013.
- Cash Position: Cash and equivalents constituted 17.9% of total assets in 2024, down from 32.0% in 2013.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, a decrease from 27.0% in 2013.
- Asset Diversification: The largest asset category is inventory at 42.6% of total assets.
MedX Health Corp Competitors by Total Assets
Key competitors of MedX Health Corp based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Cochlear Ltd
AU:COH
|
Australia | AU$2.83 Billion |
|
Vitrolife AB
ST:VITR
|
Sweden | Skr11.30 Billion |
|
Sinocare Inc
SHE:300298
|
China | CN¥6.25 Billion |
|
Shanghai Sanyou Medical Co Ltd
SHG:688085
|
China | CN¥2.34 Billion |
|
Zhejiang Orient Gene Biotech Co Ltd
SHG:688298
|
China | CN¥7.51 Billion |
|
Nanjing Vishee Medical Technology Co Ltd
SHG:688580
|
China | CN¥1.79 Billion |
|
TAIDOC TECHNOLOGY CORP
TW:4736
|
Taiwan | NT$13.07 Billion |
|
SS Innovations International Inc. Common Stock
NASDAQ:SSII
|
USA | $96.98 Million |
MedX Health Corp - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.10 | 0.09 | 0.20 |
| Quick Ratio | 0.06 | 0.05 | 0.05 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CA$-8.77 Million | CA$-8.03 Million | CA$-2.06 Million |
MedX Health Corp - Advanced Valuation Insights
This section examines the relationship between MedX Health Corp's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | - |
| Latest Market Cap to Assets Ratio | 10.73 |
| Asset Growth Rate (YoY) | 28.2% |
| Total Assets | CA$884.15K |
| Market Capitalization | $9.49 Million USD |
Valuation Analysis
Premium Asset Valuation: The market values MedX Health Corp's assets at a significant premium (10.73x), suggesting investors see substantial growth potential or unique competitive advantages.
Rapid Asset Growth: MedX Health Corp's assets grew by 28.2% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for MedX Health Corp (2013–2024)
The table below shows the annual total assets of MedX Health Corp from 2013 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | CA$884.15K ≈ $639.58K |
+28.21% |
| 2023-12-31 | CA$689.61K ≈ $498.86K |
-3.98% |
| 2022-12-31 | CA$718.23K ≈ $519.56K |
-1.76% |
| 2021-12-31 | CA$731.06K ≈ $528.84K |
-0.45% |
| 2020-12-31 | CA$734.39K ≈ $531.25K |
+68.48% |
| 2019-12-31 | CA$435.90K ≈ $315.32K |
-33.16% |
| 2018-12-31 | CA$652.16K ≈ $471.76K |
-2.80% |
| 2017-12-31 | CA$670.98K ≈ $485.38K |
-15.92% |
| 2016-12-31 | CA$798.07K ≈ $577.31K |
+22.02% |
| 2015-12-31 | CA$654.05K ≈ $473.13K |
+37.42% |
| 2014-12-31 | CA$475.94K ≈ $344.29K |
-20.70% |
| 2013-12-31 | CA$600.20K ≈ $434.18K |
-- |
About MedX Health Corp
MedX Health Corp develops, manufactures, and markets skin related screening tools and phototherapy devices for pain relief and tissue repair in Canada, the United States, Europe, and internationally. The company offers SIAscopy, a medical device technology used to scan skin for suspicious moles and lesions; and phototherapeutic medical devices, which use light energy in lower-level laser and LED … Read more